These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24273274)

  • 21. Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel.
    Su GM; Davey MW; Davey RA
    Int J Cancer; 1998 May; 76(5):702-8. PubMed ID: 9610729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells.
    Kumar Biswas S; Huang J; Persaud S; Basu A
    Mol Cancer Ther; 2004 Mar; 3(3):327-34. PubMed ID: 15026553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOXA5 inhibits metastasis via regulating cytoskeletal remodelling and associates with prolonged survival in non-small-cell lung carcinoma.
    Wang CC; Su KY; Chen HY; Chang SY; Shen CF; Hsieh CH; Hong QS; Chiang CC; Chang GC; Yu SL; Chen JJ
    PLoS One; 2015; 10(4):e0124191. PubMed ID: 25875824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
    Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
    Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DDP-sensitivity-related genes in 10 lung cancer cell lines].
    Li CH; Cai L; Chen XS; Meng QW; Sui GJ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):418-21. PubMed ID: 19024514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regulatory effect of small interfering RNA targeting multidrug resistant protein 1 on chemosensitivity of human multiforme glioblastoma cell line BT325].
    Zhao P; Zhang YZ; Sun MZ
    Ai Zheng; 2005 Dec; 24(12):1436-41. PubMed ID: 16351788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of silencing HOXA5 gene expression using RNA interference on cell cycle and apoptosis in Jurkat cells.
    Huang HP; Liu WJ; Guo QL; Bai YQ
    Int J Mol Med; 2016 Mar; 37(3):669-78. PubMed ID: 26846409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).
    Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B
    Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
    PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
    Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J
    Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Down-regulation of TopI by RNA interference reduces the drug-sensitivity of small cell lung cancer cell lines to topotecan].
    Liu XJ; Guo QS; Zhang Q; Song XR; Liu YL; Guo C
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):741-4. PubMed ID: 19173801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of MPP8 suppresses cell proliferation via regulation of HOXA5 in non-small cell lung cancer cells.
    Gao XY; Qiao YL; Zhang Y; Wang J; Shen X; Xu CW
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):27-31. PubMed ID: 29412790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of small-cell lung cancer cell-based sensor and its applications in chemotherapy effects rapid evaluation for anticancer drugs.
    Guohua H; Hongyang L; Zhiming J; Danhua Z; Haifang W
    Biosens Bioelectron; 2017 Nov; 97():184-195. PubMed ID: 28599178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.